Drug Trial Radar · NCT00097669
VITATOPS: A Study of VITAmins TO Prevent Stroke
Last checked: Nov 20, 2026Latest source record: Sep 25, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8,164
Actual
Start
Nov 1998
Primary completion
Jun 2009
Study completion Jun 2009
Sponsor
- Lead sponsor
- VITATOPSGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- National Health and Medical Research Council, Australia; National Heart Foundation, Australia; Medical Health Research Infrastructure Council, Australia
- First posted
- Nov 25, 2004
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The VITATOPS study is a multi-center, randomized, double blind, placebo-controlled secondary stroke prevention trial to determine whether the addition of vitamin supplements (B12 500 ug, B6 25 mg, Folate 2 mg) to best medical/surgical management (including modification of risk factors) will reduce the combined incidence of recurrent vascular events (stroke, myocardial infarction) and vascular death in patients with recent stroke or transient ischemic attack (TIA). All patients presenting to one of the participating neurologists or general physicians within seven months of stroke (ischemic or hemorrhagic) or TIA (eye or brain) are eligible for this trial. Eligible patients will be randomized in a double-blind fashion to receive multi-vitamins or placebo, 1 tablet daily. The primary outcome event is the composite event "stroke, myocardial infarction, or death from any vascular cause", whichever occurs first. Our target is to recruit a total of 8,000 patients over the next two years with a median follow-up of 2.5 years. Recruitment to the trial began in November 1998 and is planned to continue until December 2005. We aim to complete final follow-up by the end of 2006. However, the Steering Committee will be flexible in dictating the need for ongoing recruitment and continuing follow-up, depending on the overall rate of the primary outcome event in the entire cohort at each interim analysis.
Conditions
- Stroke
- Transient Ischemic Attack
Interventions
Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placeboDrug
multivitamin
PlaceboOther
Primary outcomes
What the sponsor says the trial is designed to measure.
- Non-fatal Stroke, Non-fatal Myocardial Infarction or Death Due to Vascular CausesTime frame: The primary outcome was measured over a median follow-up period of 3.4 years (interquartile range IQR 1.0-5.5 years).
Locations
111 sites in 20 countries. Site status is shown where the registry gives one.
JFK Hospital / Seton Hall University
New York, New York
Abington Memorial Hospital
Abington, Pennsylvania
South Carolina VA Hospital
Columbia, South Carolina
University of South Carolina
Columbia, South Carolina
Central Coast Neuroscience Research
Gosford, Australia
Bankstown Hospital
New South Wales, Australia
John Hunter Hospital
New South Wales, Australia
Liverpool Hospital
New South Wales, Australia
Royal Perth Hospital
Perth, Australia
Greenslopes Hospital
Queensland, Australia
Nambour Hospital
Queensland, Australia
Flinders & Griffiths
South Australia, Australia
Royal Hobart Hospital
Tasmania, Australia
Alfred Hospital
Victoria, Australia
Beleura & Frankston Hospital
Victoria, Australia
Box Hill Hospital
Victoria, Australia
National Stroke Research Institute - Austin Health
Victoria, Australia
Fremantle Hospital
Western Australia, Australia
Joondalup Hospital
Western Australia, Australia
Sir Charles Gairdner Hospital
Western Australia, Australia
Karl-Franzens University Graz
Graz, Austria
Algemeen Ziekenhuis Sint-Jan Autonome Verzorgingsinstelling
Bruges, Belgium
Universidade Federal Fluminense & Universidade Federal do Rio de Janeiro
Rio de Janeiro, Brazil
Sarajishvili Institute of Neurology and Neurosurgery
Tbilisi, Georgia
Queen Mary Hospital
Pokfulam, Hong Kong
Prince of Wales Hospital
Shatin, Hong Kong
Rajah Muthaiah Medical College
Annāmalainagar, India
St John's Medical College Hospital
Bangalore, India
SP Medical College
Bikaner, India
Baby Memorial Hospital
Calicut, India
KS Hospital
Chennai, India
Care Hopstial
Hyderabad, India
Mahaveer Hospital & Research Centre
Hyderabad, India
Mediciti Hospital
Hyderabad, India
MGM Medical College & MY Hospital
Indore, India
Monilek Hospital
Jaipur, India
Amrita Institute of Medical Science
Kochi, India
Centauri, The Albert Road Clinic
Kolkata, India
CSMMU
Lucknow, India
Christian Medical College & Hospital
Ludhiana, India
Showing 40 of 111 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.